Oncology Portfolio
Oncology is one of the most specialized and demanding areas of pharmaceutical sourcing. Product quality, manufacturer credibility, regulatory compliance, appropriate handling, dependable supply and continuity of availability are all critical when supporting cancer-treatment programs.
At IHIT Kenya, we simplify this complex sourcing process by connecting pharmaceutical distributors, hospitals, oncology centres, healthcare institutions and other authorized market partners with trusted international manufacturers and suitable oncology products.
Our role goes beyond locating a product. We support the sourcing journey from product identification and manufacturer evaluation through documentation coordination, regulatory and market-access support, importation, logistics and local commercial supply. By combining our international sourcing network with local market understanding, we provide a coordinated pathway to oncology products that meet specific therapeutic, technical, regulatory and commercial requirements.
Our oncology portfolio is designed to remain flexible and responsive to market needs. Depending on product availability, registration status and applicable regulatory requirements, we can explore a broad range of oncology medicines including conventional chemotherapy products, targeted therapies, monoclonal antibodies, immuno-oncology products, hormonal therapies, biosimilars and supportive-care medicines used alongside cancer treatment.
We understand that oncology procurement may involve specialized handling requirements, limited supplier options, high-value products and stringent documentation standards. Our approach therefore focuses on responsible manufacturer selection, regulatory suitability, clear communication and reliable supply planning. Where a required oncology product is not already within our portfolio, we can explore suitable sourcing opportunities through our international manufacturer network.
Key Features
- Access to reputable international manufacturers with capabilities in specialized pharmaceutical production
- Flexible sourcing across different oncology therapeutic classes, formulations and commercial positions
- Access to branded, generic and biosimilar opportunities where appropriate and commercially available
- Manufacturer and product evaluation based on quality, documentation, regulatory suitability, availability and commercial value
- Coordination of technical documentation, registration requirements and applicable market-access processes in Kenya
- Support for international procurement, shipment planning, importation, customs coordination and local delivery
- Ability to explore specific oncology products outside our existing portfolio through our global sourcing network
- Support for distributors, hospitals, oncology centres, institutions and other authorized healthcare partners
- A partnership approach focused on dependable supply, market development and sustainable long-term commercial relationships
Specifications & Portfolio Scope
Therapeutic Scope – Our sourcing capabilities may cover conventional cytotoxic chemotherapy, targeted therapies, monoclonal antibodies, immunotherapy, hormonal oncology medicines, biosimilars and supportive-care products.
Dosage Forms – Depending on the medicine and manufacturer, products may include vials, ampoules, injectable and infusion preparations, tablets, capsules and other relevant pharmaceutical presentations.
Supply Options – We can assess individual product requirements, distributor portfolio development, institutional demand and larger project- or tender-based sourcing opportunities.
Regulatory Status – Registration and market-access requirements vary by product. Products intended for commercial supply are handled according to applicable Kenyan pharmaceutical requirements, with documentation and registration processes coordinated where necessary.
Storage & Logistics – Supply arrangements are planned according to the specific storage, transportation and handling requirements of each product, including temperature-controlled logistics where applicable.

Specifications & Portfolio Scope
More Than a Supplier. Your Oncology Sourcing Partner.

More Than a Supplier. Your Oncology Sourcing Partner.
Our objective is not simply to provide quotations for oncology medicines. We aim to become a dependable sourcing and market partner capable of bringing together the right manufacturer, suitable product, regulatory pathway and commercial opportunity.
Whether you are expanding an existing oncology portfolio, responding to institutional demand, seeking a difficult-to-source molecule or looking for a reliable international manufacturing partner, IHIT Kenya provides a single point of coordination from initial product enquiry through to local market supply.
Frequently asked questions
We can explore products across major oncology treatment categories including chemotherapy, targeted therapies, monoclonal antibodies, immuno-oncology medicines, hormonal therapies, biosimilars and supportive-care products. Availability depends on the particular molecule, manufacturer, regulatory position and market requirements.
Registration status depends on the individual product. Where registration or other market-access procedures are required, we coordinate with manufacturers and relevant partners to support the necessary documentation and processes.
Yes. Sourcing flexibility is one of our core strengths. We can approach suitable international manufacturers and assess potential options based on the required molecule, strength, dosage form, quality requirements, regulatory suitability, availability and commercial considerations.
Depending on the product and applicable regulatory requirements, we work with pharmaceutical distributors, hospitals, oncology centres, clinics, healthcare institutions, specialized providers and other authorized market partners.
Yes. We can assess institutional and project-based requirements and coordinate manufacturer offers, technical documentation, pack configurations, quantities, lead times and other commercial considerations relevant to the procurement process.
Yes, where applicable. Logistics are coordinated according to each product’s specified storage and handling requirements, including temperature-controlled transportation when required.
Yes. We can support manufacturers through product and market assessment, regulatory coordination, registration support, importation, local commercial arrangements, distribution planning and market development.
Provide the product or molecule name, strength, dosage form, required quantity, preferred manufacturer or country of origin where applicable, registration status if known and delivery requirements. Our team will assess the request and identify the






